Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S A, Kalams"'
Autor:
S C Threlkeld, P A Wentworth, S A Kalams, B M Wilkes, D J Ruhl, E Keogh, J Sidney, S Southwood, B D Walker, A Sette
Publikováno v:
The Journal of Immunology. 159:1648-1657
Recent data demonstrate that HLA class I alleles can be grouped into superfamilies based on similarities of their peptide-binding motifs. In this study, we have tested the immunogenicity and antigenicity of peptides capable of degenerate binding to m
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 161(8)
CTLs play an important role in controlling cell-associated HIV. Since the majority of HIV infections are acquired through sexual transmission, we investigated whether antiviral CTLs were present in the male urogenital tract using semen as a source of
Autor:
T, Harrer, E, Harrer, S A, Kalams, P, Barbosa, A, Trocha, R P, Johnson, T, Elbeik, M B, Feinberg, S P, Buchbinder, B D, Walker
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 156(7)
Although vigorous activated and memory CTL have been associated with HIV-1 infection, data are lacking regarding the breadth of epitopes recognized in a given individual and the relationship to the viral quasispecies present in vivo. In this study we
Autor:
S A, Hammond, R P, Johnson, S A, Kalams, B D, Walker, M, Takiguchi, J T, Safrit, R A, Koup, R F, Siliciano
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 154(11)
The lysis of virally infected cells by CTLs requires the recognition of processed fragments of viral proteins presented in association with class I MHC molecules on the surfaces of infected cells. Processing begins in the cytosol with the degradation
Autor:
S A, Kalams, B D, Walker
Publikováno v:
Current topics in microbiology and immunology. 202
In summary, one can conclude that infected persons exhibit an extremely vigorous, virus-specific CTL response, and in at least some individuals this response is broadly directed at multiple epitopes. These cells are present at the time or initial con
Autor:
S A, Kalams, B D, Walker
Publikováno v:
Clinics in laboratory medicine. 14(2)
HIV infection is associated with an extremely vigorous virus-specific cytotoxic T-lymphocyte (CTL) response. This CTL activity is of sufficient magnitude to be detected using freshly isolated peripheral blood mononuclear cells, but despite this vigor
Autor:
Edupuganti S; Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, GA 30322, USA., C De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA., Elizaga M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Han X; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA., Swann E; Division of AIDS, NIH, Bethesda, MD 20892, USA., Polakowski L; Division of AIDS, NIH, Bethesda, MD 20892, USA., A Kalams S; Vanderbilt University Medical Center, Nashville, TN 37232, USA., Keefer M; Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, NY 14642, USA., Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, USA., C Wise M; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Yan J; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Morrow MP; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Khan AS; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Boyer JD; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Humeau L; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., White S; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Sardesai NY; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Bagarazzi ML; Inovio Pharmaceuticals Inc. Plymouth Meeting, PA 19462, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Weiner DB; Wistar Institute, Philadelphia, PA 19104, USA., On Behalf Of The Hvtn Study Team, The Niaid-Funded Hiv Vaccine Trials Network
Publikováno v:
Vaccines [Vaccines (Basel)] 2020 Dec 07; Vol. 8 (4). Date of Electronic Publication: 2020 Dec 07.